Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
J Comp Pathol ; 147(4): 503-7, 2012 Nov.
Article de Anglais | MEDLINE | ID: mdl-22789859

RÉSUMÉ

An 8-year-old male German longhaired pointer was referred for diabetes insipidus responsive to treatment with desmopressin. The dog had polyuria and polydipsia, exercise intolerance and a dull hair coat. Plasma concentrations of thyroid-stimulating hormone, thyroxine, growth hormone (GH) and insulin-like growth factor-1 were decreased; plasma adrenocorticotropic hormone (ACTH) was slightly elevated and plasma α-melanocyte-stimulating hormone (MSH) was within the reference range. Computed tomography revealed a heterogeneously contrast-enhancing pituitary mass compressing the hypothalamus. Transsphenoidal hypophysectomy was performed and microscopical examination of the surgical biopsy samples revealed hypophysitis without evidence of pituitary adenoma. The hypophysitis was characterized by marked lymphocytic infiltration of the adenohypophysis that contained a mixed population of neuroendocrine cells expressing GH, ACTH or α-MSH. The lymphocytes were identified as T cells, resulting in a final diagnosis of lymphocytic hypophysitis strongly resembling human primary lymphocytic hypophysitis.


Sujet(s)
Diabète insipide/médecine vétérinaire , Hypopituitarisme/médecine vétérinaire , Lymphocytes/anatomopathologie , Adénohypophyse/anatomopathologie , Hormone corticotrope/métabolisme , Animaux , Antidiurétiques/usage thérapeutique , Desmopressine/usage thérapeutique , Diabète insipide/anatomopathologie , Diabète insipide/thérapie , Maladies des chiens , Chiens , Euthanasie animale , Issue fatale , Hormone de croissance/métabolisme , Hypopituitarisme/métabolisme , Hypopituitarisme/anatomopathologie , Hypopituitarisme/thérapie , Mâle , Cellules neuroendocrines/métabolisme , Cellules neuroendocrines/anatomopathologie , Adénohypophyse/métabolisme , Hormone mélanotrope alpha/métabolisme
2.
J Vet Intern Med ; 22(1): 66-73, 2008.
Article de Anglais | MEDLINE | ID: mdl-18289291

RÉSUMÉ

BACKGROUND: Glomerular filtration rate (GFR) decreases in the aging human kidney, but limited data exist in dogs. HYPOTHESIS: There is an effect of age and body size on estimated GFR in healthy dogs. ANIMALS: One hundred and eighteen healthy dogs of various breeds, ages, and body weights presenting to 3 referral centers. METHODS: GFR was estimated in clinically healthy dogs between 1 and 14 years of age. GFR was estimated from the plasma clearance of iohexol, by a compartmental model and an empirical correction formula, normalized to body weight in kilograms or liters of extracellular fluid volume (ECFV). For data analysis, dogs were divided into body weight quartiles 1.8-12.4, 13.2-25.5, 25.7-31.6, and 32.0-70.3 kg. RESULTS: In the complete data set, there was no trend toward lower estimated GFR/kg or GFR/ECFV with increasing age. GFR decreased with age in dogs in the smallest weight quartile only. A significant negative linear relationship was detected between body weight and estimated GFR/kg and GFR/ECFV. Reference ranges in different weight quartiles were 1.54-4.25, 1.29-3.50, 0.95-3.36, and 1.12-3.39 mL/min/kg, respectively. Standardization to ECFV rather than kilogram body weight did not produce substantial changes in the relationships between GFR estimates and age or weight. CONCLUSIONS AND CLINICAL IMPORTANCE: Interpretation of GFR results for early diagnosis of renal failure should take into account the weight and the age of the patient for small dogs.


Sujet(s)
Produits de contraste/pharmacocinétique , Chiens/métabolisme , Débit de filtration glomérulaire/médecine vétérinaire , Iohexol/pharmacocinétique , Vieillissement , Animaux , Poids , Chiens/sang , Débit de filtration glomérulaire/physiologie , Rein/métabolisme
3.
Vet Q ; 20(1): 28-31, 1998 Jan.
Article de Anglais | MEDLINE | ID: mdl-9477533

RÉSUMÉ

Seventeen dogs with mast cell tumours received chemotherapy. Fifteen dogs were treated with a vincristine, cyclophosphamide, hydroxyurea, and prednisolone (VCHP) regimen. Seven of these were later switched to doxyrubicin and prednisolone either because they stopped responding or because they did not respond from the start of the treatment. Two dogs received the latter regimen as the primary therapy. All dogs were treated with cimitidine and metoclopramide to minimize the effect of paraneoplastic syndrome associated with histamine release. Ten of the 17 dogs were found to respond (4/17 complete response (CR), 6/17 partial response (PR)). Response duration varied from 39 to 910 days (median 53 days), including 3 dogs with a CR that lasted more than 2 years. Survival time in responders varied from 41 to 910 days (median 97 days) and from 30 to 126 (median 39) in the other 7 dogs. Dogs that became refractory to VCHP did not respond to doxyrubicin and prednisolone. It is concluded that multi-agent chemotherapy has anti-tumour activity in a considerable proportion of dogs with mast cell tumours, but its efficacy is variable. The multivariate analyses showed that significant factors predicting survival in dogs with mast cell tumours were sex (P = 0.009), absence or presence of non-abdominal distant metastases, or abdominal metastases, respectively (P = 0.023), and malignancy grade of the tumours (P = 0.053).


Sujet(s)
Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Maladies des chiens/traitement médicamenteux , Sarcome à mastocytes/médecine vétérinaire , Tumeurs cutanées/médecine vétérinaire , Animaux , Cyclophosphamide/usage thérapeutique , Chiens , Doxorubicine/administration et posologie , Femelle , Hydroxy-urée/usage thérapeutique , Mâle , Sarcome à mastocytes/traitement médicamenteux , Sarcome à mastocytes/anatomopathologie , Métastase tumorale , Prednisolone/administration et posologie , Prednisolone/usage thérapeutique , Tumeurs cutanées/traitement médicamenteux , Tumeurs cutanées/anatomopathologie , Analyse de survie , Vincristine/usage thérapeutique
4.
Vet Q ; 18(2): 49-51, 1996 Jun.
Article de Anglais | MEDLINE | ID: mdl-8792593

RÉSUMÉ

Atrial fibrillation (AF) and primary hypothyroidism are most often diagnosed in middle-aged and older dogs of large and giant breeds. We hypothesized that the frequency of primary hypothyroidism may be higher in dogs with AF than in those without AF. Two groups were investigated. Group 1 (March 1987-June 1990) consisted of 128 dogs with AF. A thyroid-stimulating hormone (TSH) stimulation test was performed in dogs with a low voltage on the ECG and low uptake of pertechnetate on a thyroid scan. Group 2 (July 1990-July 1991) consisted of both dogs with AF (n = 38) and control dogs (n = 235) in which plasma thyroxine (T4) was measured. If T4 was below 15 nmol/l, a TSH stimulation test was performed. The frequencies of primary hypothyroidism in group 1 (8/128) and in the group 2 AF dogs (3/38) were not different, but were higher than in the control animals (3/235) (P < 0.05). The group 1 and the group 2 AF dogs were found to be comparable, and pooling of the data of the two groups enhanced the significance of the frequency of primary hypothyroidism in dogs with AF versus the control animals (11/166 versus 3/235) (P < 0.01). We concluded that the frequency of primary hypothyroidism in dogs with AF is higher than in the group of control dogs without AF. This may be due to the additional cardiovascular changes accompanying primary hypothyroidism in dogs that already have heart disease.


Sujet(s)
Fibrillation auriculaire/médecine vétérinaire , Maladies des chiens/épidémiologie , Chiens/physiologie , Hypothyroïdie/médecine vétérinaire , Animaux , Fibrillation auriculaire/complications , Fibrillation auriculaire/épidémiologie , Phénomènes physiologiques cardiovasculaires , Système cardiovasculaire/effets des médicaments et des substances chimiques , Maladies des chiens/diagnostic , Maladies des chiens/physiopathologie , Chiens/sang , Électrocardiographie/médecine vétérinaire , Femelle , Hypothyroïdie/complications , Hypothyroïdie/épidémiologie , Incidence , Mâle , Pertechnétate (99mTc) de sodium/pharmacocinétique , Thyréostimuline/pharmacologie , Thyroxine/sang
5.
Vet Q ; 18(2): 63-5, 1996 Jun.
Article de Anglais | MEDLINE | ID: mdl-8792597

RÉSUMÉ

This report describes nine unrelated cats with acute idiopathic polyneuropathy. All cats presented with acutely developing tetraparesis or tetraparalysis and loss of spinal reflexes. Seven cats recovered completely within 4 to 6 weeks, without any medication. Two years after complete recovery, none of these cats had had a relapse. In the acute stage, two cats were euthanized because of respiratory complications. Postmortem examination was performed on one of these cats and revealed generalized peripheral motor polyneuropathy. The clinical signs in these cats were identical to those of the Guillain-Barré syndrome in humans.


Sujet(s)
Maladies des chats/diagnostic , Chats/physiologie , Maladies du système nerveux/médecine vétérinaire , Maladie aigüe , Animaux , Maladies des chats/anatomopathologie , Maladies des chats/physiopathologie , Femelle , Mâle , Activité motrice/physiologie , Maladies du système nerveux/diagnostic , Maladies du système nerveux/étiologie , Paralysie/étiologie , Paralysie/physiopathologie , Paralysie/médecine vétérinaire , Parésie/étiologie , Parésie/physiopathologie , Parésie/médecine vétérinaire , Racines des nerfs spinaux/anatomopathologie , Racines des nerfs spinaux/physiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...